Inventor

Robert Graziano

Inventor
Frenchtown, NJ, US

Overview

23→
Patents
1994–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 23 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary
C07KPeptides26%
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C12NMicroorganisms or enzymes6%
G01NInvestigating or analysing materials by determining their chemical or physical properties6%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests6%
A01KAnimal husbandry2%
Y02ATechnologies for adaptation to climate change2%
G01SRadio direction-finding1%
PatentTitleYear
10,688,180Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer20209,789,182'Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer'20179,217,029'Antibodies against clostridium difficile toxins and uses thereof'20158,609,111'Antibodies against clostridium difficile toxins and uses thereof'20138,257,709'Antibodies against Clostridium difficile toxins and uses thereof'20128,236,311'Antibodies against clostridium difficile toxins and uses thereof'20128,142,778'Methods of treatment using CTLA-4 antibodies'20128,088,377'Human monoclonal antibodies against CD30'20127,625,559'Antibodies against Clostridium difficile toxins and uses thereof'20097,452,535'Methods of treatment using CTLA-4 antibodies'20087,387,776'Human monoclonal antibodies against CD30'20087,378,504'Human monoclonal antibodies to Fc gamma receptor I (CD64)'20087,316,812'Cells expressing anti-Fc receptor binding components'20086,682,928'Cells expressing anti-Fc receptor binding components'20046,410,690'Therapeutic compounds comprised of anti-Fc receptor antibodies'20026,395,272'Therapeutic compounds comprised of anti-Fc receptor antibodies'20026,365,161'Therapeutic compounds comprised of anti-FC receptor binding agents'20026,303,755'Therapeutic multispecific compounds comprised of anti-FCA receptor antibodies'20016,270,765'Therapeutic compounds comprised of anti-Fc receptor antibodies'20016,193,966'Therapeutic multispecific compounds comprised of anti-Fc.alpha. receptor antibodies'20015,922,845'Therapeutic multispecific compounds comprised of anti-Fc.alpha. receptor antibodies'19995,837,243'Therapeutic compounds comprised of anti-Fc receptor antibodies'19985,313,214'Scaled multiple function nonlinear FM waveform'1994

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1994Based in Coram, NY, US· patent location history
1998–2012Patents assigned to MEDAREX INC (15)· patent assignee history
1998–2020Based in Frenchtown, NJ, US· patent location history
2008–2012Based in Princeton, NJ, US· patent location history
2009–2015Patents assigned to UNIV MASSACHUSETTS (5)· patent assignee history
2012–2013Patents assigned to GRAZIANO ROBERT (4)· patent assignee history
2012–2013Patents assigned to AMBROSINO DONNA M (3)· patent assignee history
2012–2013Patents assigned to BABCOCK GREGORY J (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MEDAREX INC151998–2012
UNIV MASSACHUSETTS52009–2015
GRAZIANO ROBERTself42012–2013
AMBROSINO DONNA M32012–2013
BABCOCK GREGORY J32012–2013
Locations
LocationPatentsSpan
Frenchtown, New Jersey, US201998–2020
Princeton, New Jersey, US22008–2012
Coram, New York, US11994